Home/Filings/4/0001127602-24-029990
4//SEC Filing

Millham Brian 4

Accession 0001127602-24-029990

CIK 0001108524other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 8:22 PM ET

Size

37.0 KB

Accession

0001127602-24-029990

Insider Transaction Report

Form 4
Period: 2024-12-22
Millham Brian
Advisor to CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2024-12-22+1,6341,634 total
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2024-12-232,03855,019 total
    Exercise: $186.51From: 2024-03-22Exp: 2030-03-22Common Stock (2,038 underlying)
  • Sale

    Common Stock

    2024-12-23$339.78/sh857$291,1881,662 total
  • Exercise/Conversion

    Common Stock

    2024-12-23$215.17/sh+2,018$434,2135,718 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-12-221,6341,635 total
    Exercise: $0.00From: 2022-03-22Exp: 2025-03-22Common Stock (1,634 underlying)
  • Sale

    Common Stock

    2024-12-23$339.78/sh821$278,9562,519 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-12-221,7068,533 total
    Exercise: $0.00From: 2023-03-22Exp: 2026-03-22Common Stock (1,706 underlying)
  • Exercise/Conversion

    Common Stock

    2024-12-22+1,7063,340 total
  • Exercise/Conversion

    Common Stock

    2024-12-23$218.21/sh+2,107$459,7687,825 total
  • Exercise/Conversion

    Common Stock

    2024-12-23$240.95/sh+8,646$2,083,25416,471 total
  • Sale

    Common Stock

    2024-12-23$340.02/sh4,536$1,542,3138,184 total
  • Sale

    Common Stock

    2024-12-23$342.25/sh5,922$2,026,8051,662 total
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2024-12-232,0186,054 total
    Exercise: $215.17From: 2022-03-22Exp: 2028-03-22Common Stock (2,018 underlying)
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2024-12-238,64617,292 total
    Exercise: $240.95From: 2022-02-22Exp: 2028-02-22Common Stock (8,646 underlying)
  • Exercise/Conversion

    Common Stock

    2024-12-23$186.51/sh+2,038$380,1073,700 total
  • Sale

    Common Stock

    2024-12-23$339.36/sh3,751$1,272,95112,720 total
  • Sale

    Common Stock

    2024-12-23$341.04/sh600$204,6217,584 total
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2024-12-232,10731,600 total
    Exercise: $218.21From: 2023-03-22Exp: 2029-03-22Common Stock (2,107 underlying)
Footnotes (12)
  • [F1]Represents a sale of shares to satisfy the tax withholding obligations of the Issuer with respect to the settlement of shares that were earned by the holder pursuant to a restricted stock unit award that vested based on the holder's continued employment through December 22, 2024.
  • [F10]Option vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
  • [F11]Option vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
  • [F12]Option vests over four years at the rate of 25% on February 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
  • [F2]As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2023.
  • [F3]Weighted average price. These shares were sold in multiple transactions at prices ranging from $338.7600 to $339.7300 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F4]Weighted average price. These shares were sold in multiple transactions at prices ranging from $339.7600 to $340.4350 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F5]Weighted average price. These shares were sold in multiple transactions at prices ranging from $340.8500 to $341.6600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F6]Restricted Stock Units convert to shares of common stock on a one-for-one basis.
  • [F7]These restricted stock units vest as to 25% of the original grant on March 22, 2022, and vest as to 1/16 of the original grant quarterly thereafter.
  • [F8]These restricted stock units vest as to 25% of the original grant on March 22, 2023, and vest as to 1/16 of the original grant quarterly thereafter.
  • [F9]Option vests over four years at the rate of 25% on March 22, 2024, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Issuer

Salesforce, Inc.

CIK 0001108524

Entity typeother

Related Parties

1
  • filerCIK 0001943041

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 8:22 PM ET
Size
37.0 KB